Bioequivalence and Phase I Clinical Studies (PK/PD)
Since 2005, Synvia has been conducting clinical and bioanalytical studies, including bioequivalence studies in healthy participants and patients, with complete infrastructure, specialized staff, and compliance with the highest international regulatory standards.
of excellence
Regulatory harmonization for global bioequivalence studies
Harmonized protocols according to ANVISA, EMA, and FDA, with standardized methods and global documentation to reduce timelines and simplify the international registration of medicines.
Certified quality
We operate with full adherence to international standards of quality, safety, and scientific ethics, following FDA and EMA guidelines.
20,000 m² of complete infrastructure, ready for bioequivalence studies
Complete installations that meet end-to-end projects, ensuring maximum efficiency and agility.
Integrated bioanalytical laboratory with the clinical center
Our technical team consists of dozens of masters and doctors specialized in the development and validation of bioanalytical methods. The integration between the laboratory and the clinical center ensures operational efficiency, traceability, and global compliance.
+100 thousand
samples/month
+500
bioanalytical methods
The largest analytical park in Latin America for mass spectrometry
Our modern facilities include state-of-the-art equipment, such as:
Excellence at every stage of study
From feasibility to final delivery, our technical and operational areas work together to ensure quality, agility, and full regulatory compliance.
Pharma Solutions
Integrated solutions for the pharmaceutical industry
From clinical research to laboratory analyses and regulatory studies, our Pharma solutions connect all the necessary steps for the development, validation, and registration of medications.
Tailored studies for high-complexity projects
We conduct customized projects with technical expertise and regulatory support.
